Suchergebnisse - "FUSHIDA, S"

PubPharm (192)

1

Peripheral Blood Platelet–Lymphocyte Ratio Is Good Predictor of Chemosensitivity and Prognosis in Gastric Cancer Patients

in: Cancer Management and Research | 2020

von Ohe Y | Fushida S | Yamaguchi T | +7

2

The effect of HIF-1a and PKM1 expression on acquisition of chemoresistance

in: Cancer Management and Research | 2018

von Okazaki M | Fushida S | Tsukada T | +6

3

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

in: Cancer Management and Research | 2018

von Kurata T | Fushida S | Kinoshita J | +7

4

Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation : A Case Report

enthalten in: Transplantation proceedings | 2017

von Nakanuma, S. | Miyashita, T. | Hayashi, H. | +11

5

Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation: A Case Report

enthalten in: Transplantation proceedings | 2017

von Nakanuma, S. | Miyashita, T. | Hayashi, H. | +11

6

Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregation

enthalten in: European surgery : ACA : Acta chirurgica Austriaca | 2016

von Miyashita, T. | Nakanuma, S. | Ahmed, A. | +10

7

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

in: Drug Design, Development and Therapy | 2016

von Fushida S | Kinoshita J | Kaji M | +5

8

P-206Effects of eribulin mesilate for tumor progression and fibrosis in gastric cancer

enthalten in: Annals of oncology | 2016

von Kurata, T. | Fushida, S. | Tsukada, T. | +3

9

P-283Paclitaxel plus valproic acid versus paclitaxel alone as second or third line therapy for advanced gastric cancer: a randomized phase 2 trial

enthalten in: Annals of oncology | 2016

von Kinoshita, J. | Fushida, S. | Kaji, M. | +8

10

P-034The potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated by preoperative docetaxel, cisplatin, and S-1

enthalten in: Annals of oncology | 2016

von Fushida, S. | Saito, H. | Kurata, T. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]